News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Haddadin Yezan Munther
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
4
| Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 358,337 options to buy
@ $0.24, valued at
$86k
|
|
| 03/31/2023 |
4
| Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 41,065 options to buy
@ $1.05, valued at
$43.1k
|
|
| 10/11/2022 |
4
| Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Bought 29,743 shares
@ $1.29, valued at
$38.4k
Bought 3,600 shares
@ $1.27, valued at
$4.6k
|
|
| 10/07/2022 |
4
| Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 71,998 options to buy
@ $1.25, valued at
$90k
|
|
| 03/24/2022 |
4
| Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 21,878 options to buy
@ $1.92, valued at
$42k
|
|
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/22/2020 |
4
| Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $0.7245, valued at
$7.2k
|
|
| 07/21/2020 |
4
| Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 135,000 options to buy
@ $1.58, valued at
$213.3k
|
|
| 03/20/2020 |
4
| Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.54, valued at
$8.1k
|
|
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2017 |
4
| Haddadin Yezan Munther (Director) has filed a Form 4 on Oncobiologics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.26, valued at
$31.5k
|
|
|
|